Related Experiment Video
Updated: Jun 14, 2026
10:16
Electroactive Polymer Nanoparticles Exhibiting Photothermal Properties
Published on: January 8, 2016
Electrochemically controlled drug delivery based on intrinsically conducting polymers.
Darren Svirskis1, Jadranka Travas-Sejdic, Anthony Rodgers
1School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
Summary
Intrinsically conducting polymers (ICPs) offer electrically controlled drug release. Future intelligent drug delivery systems will self-adjust dosage based on the body's environment.
Area of Science:
- Materials Science
- Biomedical Engineering
- Polymer Chemistry
Background:
- Intrinsically conducting polymers (ICPs) possess unique electrical, magnetic, and optical properties alongside polymer processing advantages.
- Electrical stimulation of ICPs can modulate their redox state, directly influencing drug release kinetics.
- ICP-based drug delivery systems (DDS) have evolved from early reports in the 1980s to recent clinical applications.
Purpose of the Study:
- To review the synthesis, properties, and pharmaceutical applications of ICPs for drug delivery.
- To examine existing literature on ICP-based DDS, focusing on drug incorporation and release mechanisms.
- To explore the potential of ICPs in developing next-generation intelligent drug delivery systems.
Main Methods:
- Literature review of ICP synthesis and characterization relevant to DDS.
- Analysis of studies detailing drug loading and release profiles from ICP matrices.
- Discussion of biodegradability, biocompatibility, and pharmaceutical applications of ICPs.
Main Results:
- ICPs enable controlled drug release modulated by electrical stimulation.
- Recent clinical applications demonstrate the viability of ICP-based DDS.
- The combination of biosensing and drug delivery in ICPs paves the way for intelligent DDS.
Conclusions:
- ICPs show significant promise for implantable drug delivery, allowing external dose adjustment.
- Optimizing the benefit-to-side effect ratio and patient adherence are key advantages.
- Future ICP-based DDS could offer self-adjusting drug release in response to physiological changes.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...